47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study)

• Nahid Daneshi ,
• Abdolreza Esmaeilzadeh ,
• Nazila Bahmaie

Affiliations

Nahid Daneshi

Zanjan University of Medical Sciences (ZUMS) Faculty of Medicine, Zanjan, Iran

Abdolreza Esmaeilzadeh

Department of Immunology, Zanjan University of Medical Sciences (ZUMS) Faculty of Medicine, Zanjan, Iran; Immunotherapy Research & Technology Group, Zanjan University of Medical Sciences, Zanjan (ZUMS), Iran

Nazila Bahmaie

Department of Medical Biology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research, Network (USERN), Tehran, Iran